Influenzanet is a system to monitor the activity of influenza-like-illness (ILI) with the aid of volunteers via the internet

http://www.influenzanet.info/

Epiwork Logo
Developing the framework for an epidemic forecast infrastructure.
http://www.epiwork.eu/

The Seventh Framework Programme (FP7) bundles all research-related EU initiatives.

7th Framework Logo
Participating countries and volunteers:

The Netherlands 0
Belgium 0
Portugal 2391
Italy 0
Great Britain 0
Sweden 0
Germany 0
Austria 0
Switzerland 2722
France 7008
Spain 0
Ireland 0
InfluenzaNet is a system to monitor the activity of influenza-like-illness (ILI) with the aid of volunteers via the internet. It has been operational in The Netherlands and Belgium (since 2003), Portugal (since 2005) and Italy (since 2008), and the current objective is to implement InfluenzaNet in more European countries.

In contrast with the traditional system of sentinel networks of mainly primary care physicians coordinated by the European Influenza Surveillance Scheme (EISS), InfluenzaNet obtains its data directly from the population. This creates a fast and flexible monitoring system whose uniformity allows for direct comparison of ILI rates between countries.

Any resident of a country where InfluenzaNet is implemented can participate by completing an online application form, which contains various medical, geographic and behavioural questions. Participants are reminded weekly to report any symptoms they have experienced since their last visit. The incidence of ILI is determined on the basis of a uniform case definition.

Hide this information

Efectividade da Vacina no Reino Unido

Efectividade da Vacina no Reino Unido

Dados referentes ao Reino Unido publicados esta semana sobre esta época gripal apontam para que a estirpe A(H1N1)pdm09 foi a predominante. Esta estirpe está incluída na vacina sazonal distribuída no Reino Unido, e corresponde à estirpe pandémica que circulou em 2009, durante a pandemia.

A estimativa da efectividade da vacina a meio da época aponta para 41,5% nos casos de gripe confirmados laboratorialmente e diagnosticados nas consultas de cuidados primários (Médicos de Família) e de 49,1% (IC 95%: 9,3-71,5) espeificamente para a estirpe  A(H1N1)pdm09. Estas estimativas mostram níveis de protecção idênticos aos da temporada 2010/11, quando esta estirpe foi usado pela primeira vez na vacina sazonal.

Fonte: Eurosurveillance (Artigo original

4 de April de 2016 às 12:32